Healthcare Industry News: HSMN NewsFeed

Biopharmaceuticals Gastroenterology FDA

 News Release - October 23, 2020

GI Supply Gets FDA Clearance for its Submucosal Lifting Agent in a Second Size, a Pre-filled 10mL Syringe

New EverLift™ device designed to reduce costs and enhance complete polyp resections

MECHANICSBURG, Pa., Oct. 23, 2020 -- (Healthcare Sales & Marketing Network) -- GI Supply today announced the FDA clearance of EverLift™ Submucosal Lifting Agent in a 10mL syringe, a new device for the lift of polyps, adenomas, early-stage cancers and other gastrointestinal lesions prior to excision with a snare or other appropriate endoscopic devices.

EverLift is the only pre-filled Submucosal Lifting Agent in the market available in two presentations, 5mL and 10mL, providing physicians flexibility to use only what they need and potentially reducing costs to hospitals and ambulatory surgery centers. Also, the pre-filled syringe eliminates the time and expense associated with mixing and preparing the agent.

The new EverLift device provides margin delineation of the lesions with a darker blue color than that offered by other manufacturers1. The darker color is intended to enable safe and complete polyp resections.

"Lifting agents aid in safer resections for patients. EverLift provides a pliable yet reliable cushion for resection and darker blue hues. The single serve dosing helps reduce waste for everyday polypectomies." – Dr. Gary "Taavi" Reiss Assistant Professor of Clinical Medicine LSU Health and Director of Interventional GI Metropolitan Gastroenterology Associates.

EverLift's formulation is cellulose based, making it hypertonic. This results in a lifting agent that is specially formulated with water-retaining properties, which causes a slower rate of absorption because of osmotic resistance. With an absorption rate slower than other currently available agents2, EverLift provides gastroenterologists with a long lift during their resection procedures.

"The launch of EverLift 10mL completes our offering as now we have two separate presentations of lifting agents in a 5mL and 10mL syringe, to give physicians more flexibility. We are committed to continue to invest on innovation and this launch is another proof of our continuous investments," said GI Supply CFO and Interim CEO Kristi Dahlke.

Click here and scroll down to the "Documentation" Tab to see how EverLift supports the needs of GIs and review the Instructions for Use.

About GI Supply

As a physician-founded company, we strive for deep clinical input into all that we do. GI Supply is broadening our portfolio with solutions that allow physicians to perform more-advanced procedures safely, efficiently and economically. We help doctors do their jobs faster, safer and simpler. For more information visit www.gi-supply.com.
  1. Survey conducted at DDW, 2019
  2. Based on ex-vivo bench top studies and not in clinical use.


Source: GI Supply

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.